Literature DB >> 30322517

A biopsychosocial model of resilience for breast cancer: A preliminary study in mainland China.

Zeng Jie Ye1, Chao Hua Peng2, Hao Wei Zhang3, Mu Zi Liang4, Jing Jing Zhao5, Zhe Sun6, Guang Yun Hu7, Yuan Liang Yu8.   

Abstract

PURPOSE: Patients diagnosed with breast cancer exhibited critical biopsychosocial functions following surgery or adjuvant treatment; therefore, it is important that they exhibit resilience. A Resilience Model for Breast Cancer (RM-BC) was developed using Chinese breast cancer patients to increase our understanding of how resilience outcomes are positively and negatively affected by protective and risk factors, respectively.
METHODS: Chinese women with breast cancer completed the questionnaires within 1 week of beginning treatment. Exploratory Structural Equation Modeling was used to evaluate the RM-BC using a sample size of 342 patients.
RESULTS: RM-BC suggested satisfactory goodness-of-fit indices and 67 percents of variance for resilience was explained. The Fit Indices for the measurement model were as follows: CFI = 0.909, GFI = 0.911, IFI = 0.897, NFI = 0.922, PNFI = 0.896, PCFI = 0.884, and RMSEA = 0.031. Three risk factors - emotional distress, physical distress, and intrusive thoughts - and four protective factors - self-efficacy, social support, courage-related strategy, and hope - were recognized.
CONCLUSION: The resilience model allows for a better understanding of Chinese breast cancer patients' resilience integration while undergoing treatment and provides an effective structure for the development of resilience-focused interventions that are grounded in their experiences. A randomized trial has provided evidences of feasibility in Chinese women with breast cancer and the resilience model could be used as a useful framework for more resilience intervention in the future.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biopsychosocial adjustment; Breast cancer; Mainland China; Oncology; RM-BC; Resilience model; SEM

Mesh:

Year:  2018        PMID: 30322517     DOI: 10.1016/j.ejon.2018.08.001

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  4 in total

1.  Resilience process and its protective factors in long-term survivors after lung cancer surgery: a qualitative study.

Authors:  Xuting Li; Shihao Chen; Jingping Zhang; Lezhi Li; Yingxia Li; Man Ye
Journal:  Support Care Cancer       Date:  2020-07-18       Impact factor: 3.603

2.  Resilience index improves prediction of 1-year decreased quality of life in breast cancer.

Authors:  Mu Zi Liang; Ying Tang; M Tish Knobf; Alex Molassiotis; Peng Chen; Guang Yun Hu; Zhe Sun; Yuan Liang Yu; Zeng Jie Ye
Journal:  J Cancer Surviv       Date:  2022-08-06       Impact factor: 4.062

3.  Positive personal resources and psychological distress during the COVID-19 pandemic: resilience, optimism, hope, courage, trait mindfulness, and self-efficacy in breast cancer patients and survivors.

Authors:  Francesca Chiesi; Deborah Vizza; Moira Valente; Rosy Bruno; Chloe Lau; Maria Rosita Campagna; Melania Lo Iacono; Francesco Bruno
Journal:  Support Care Cancer       Date:  2022-05-17       Impact factor: 3.359

4.  Minimum clinical important difference for resilience scale specific to cancer: a prospective analysis.

Authors:  Zeng Jie Ye; Zhang Zhang; Ying Tang; Jian Liang; Xiao Ying Zhang; Guang Yun Hu; Zhe Sun; Mu Zi Liang; Yuan Liang Yu
Journal:  Health Qual Life Outcomes       Date:  2020-12-09       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.